Brazil continues to define its pharmaceutical serialization and traceability regulations. RDC 157provides guidance for the implementation of the National Medicine Control System (SNCM) and the mechanism and procedures for drug tracking from the activation of the individual drug until the dispense to the consumer.
The country and pharma stakeholders who manufacture or import in Brazil are in the process of implementing the law through a series of phases with the next big milestone requiring full traceability approaching fast.
In this guide learn how to take a practical approach to comply with the Brazil serialization requirements.
